دورية أكاديمية
أعرض في EDS

m 6 A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication.

التفاصيل البيبلوغرافية
العنوان: m 6 A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication.
المؤلفون: Manners O; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Baquero-Perez B; Molecular Virology Unit, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain., Mottram TJ; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Yonchev ID; Sheffield Institute for Nucleic Acids, School of Biosciences, University of Sheffield, Firth Court, Western Bank, Sheffield S10 2TN, UK., Trevelyan CJ; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Harper KL; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Menezes S; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Patterson MR; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Macdonald A; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK., Wilson SA; Sheffield Institute for Nucleic Acids, School of Biosciences, University of Sheffield, Firth Court, Western Bank, Sheffield S10 2TN, UK., Aspden JL; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.; LeedsOmics, University of Leeds, Leeds LS2 9JT, UK., Whitehouse A; School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre of Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.; Department of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa.
المصدر: Viruses [Viruses] 2023 Jun 16; Vol. 15 (6). Date of Electronic Publication: 2023 Jun 16.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مواضيع طبية MeSH: Herpesvirus 8, Human*/genetics, Virus Latency/genetics ; Cell Line, Tumor ; Signal Transduction ; RNA, Messenger/genetics ; Virus Replication ; Gene Expression Regulation, Viral
مستخلص: The epitranscriptomic modification N 6 -methyladenosine (m 6 A) is a ubiquitous feature of the mammalian transcriptome. It modulates mRNA fate and dynamics to exert regulatory control over numerous cellular processes and disease pathways, including viral infection. Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation from the latent phase leads to the redistribution of m 6 A topology upon both viral and cellular mRNAs within infected cells. Here we investigate the role of m 6 A in cellular transcripts upregulated during KSHV lytic replication. Our results show that m 6 A is crucial for the stability of the GPRC5A mRNA, whose expression is induced by the KSHV latent-lytic switch master regulator, the replication and transcription activator (RTA) protein. Moreover, we demonstrate that GPRC5A is essential for efficient KSHV lytic replication by directly regulating NFκB signalling. Overall, this work highlights the central importance of m 6 A in modulating cellular gene expression to influence viral infection.
References: Viruses. 2020 Sep 17;12(9):. (PMID: 32957532)
Cell Host Microbe. 2008 Jan 17;3(1):1-3. (PMID: 18191785)
Cancer Cell Int. 2017 Mar 2;17:34. (PMID: 28270740)
Cancer Lett. 2021 Jul 28;511:36-46. (PMID: 33933553)
Front Microbiol. 2012 Feb 20;3:59. (PMID: 22363332)
J Virol. 1999 Dec;73(12):9756-63. (PMID: 10559285)
Nat Microbiol. 2016 Oct 31;2:16201. (PMID: 27798559)
Virology. 2004 Aug 1;325(2):225-40. (PMID: 15246263)
J Virol. 1997 Jan;71(1):715-9. (PMID: 8985403)
Nucleic Acids Res. 2014 Dec 16;42(22):13911-9. (PMID: 25389274)
Mol Cell. 2019 May 16;74(4):640-650. (PMID: 31100245)
Virology. 2008 May 25;375(1):94-102. (PMID: 18321555)
Cell Host Microbe. 2016 Nov 9;20(5):654-665. (PMID: 27773535)
PLoS Pathog. 2018 Apr 16;14(4):e1006995. (PMID: 29659627)
Front Microbiol. 2016 Feb 01;7:54. (PMID: 26870016)
Virology. 1998 Dec 20;252(2):304-12. (PMID: 9878608)
Nat Protoc. 2013 Jan;8(1):176-89. (PMID: 23288318)
J Virol. 2019 Feb 19;93(5):. (PMID: 30541837)
Nat Microbiol. 2018 Jan;3(1):108-120. (PMID: 29109479)
PLoS Pathog. 2015 Nov 20;11(11):e1005274. (PMID: 26587836)
J Gen Virol. 2000 Sep;81(Pt 9):2253-2265. (PMID: 10950983)
J Virol. 1998 Oct;72(10):8309-15. (PMID: 9733875)
Nat Rev Mol Cell Biol. 2019 Oct;20(10):608-624. (PMID: 31520073)
Methods Cell Biol. 2016;132:3-23. (PMID: 26928536)
Front Microbiol. 2022 Jun 15;13:870816. (PMID: 35783391)
Genes Dev. 2020 Oct 1;34(19-20):1373-1391. (PMID: 32943573)
Front Cell Dev Biol. 2021 Feb 09;9:634160. (PMID: 33634132)
Front Microbiol. 2012 Feb 14;3:30. (PMID: 22347875)
Biochem Pharmacol. 2016 Aug 15;114:69-81. (PMID: 27060663)
J Clin Invest. 2010 Apr;120(4):939-49. (PMID: 20364091)
Nat Chem Biol. 2014 Feb;10(2):93-5. (PMID: 24316715)
J Exp Med. 2004 Aug 2;200(3):391-8. (PMID: 15289507)
Nature. 2017 Jan 19;541(7637):371-375. (PMID: 28002401)
Curr Opin Virol. 2018 Oct;32:60-70. (PMID: 30268927)
PLoS Pathog. 2015 Mar 20;11(3):e1004771. (PMID: 25794275)
Nat Chem Biol. 2011 Oct 16;7(12):885-7. (PMID: 22002720)
Adv Virus Res. 2014;88:111-59. (PMID: 24373311)
EMBO Rep. 2022 May 4;23(5):e54117. (PMID: 35239998)
Nat Microbiol. 2016 Feb 22;1:16011. (PMID: 27572442)
PLoS Pathog. 2019 Jun 21;15(6):e1007835. (PMID: 31226168)
Elife. 2019 Oct 24;8:. (PMID: 31647415)
Nature. 2012 Apr 29;485(7397):201-6. (PMID: 22575960)
Oncol Rep. 2016 Nov;36(5):2983-2990. (PMID: 27599526)
J Virol. 2009 Jul;83(13):6727-38. (PMID: 19369342)
Mol Cell. 2013 Jan 10;49(1):18-29. (PMID: 23177736)
J Virol. 2003 Apr;77(7):4205-20. (PMID: 12634378)
Cell. 2012 Jun 22;149(7):1635-46. (PMID: 22608085)
J Virol. 2003 Aug;77(15):8532-40. (PMID: 12857922)
Nat Commun. 2023 Jan 18;14(1):300. (PMID: 36653366)
J Cell Sci. 2011 Dec 1;124(Pt 23):3933-40. (PMID: 22194304)
Oncoscience. 2014 Nov 25;1(12):765-76. (PMID: 25621293)
PLoS Pathog. 2018 Sep 6;14(9):e1007276. (PMID: 30188954)
J Biomed Sci. 2023 Mar 14;30(1):18. (PMID: 36918845)
J Gen Virol. 2017 Sep;98(9):2207-2214. (PMID: 28869001)
Trends Microbiol. 2020 Mar;28(3):236-237. (PMID: 31759828)
PLoS Pathog. 2014 Jan;10(1):e1003847. (PMID: 24453964)
Genome Biol. 2023 Jan 24;24(1):17. (PMID: 36694229)
Viruses. 2021 Jun 01;13(6):. (PMID: 34205979)
Front Biosci. 2007 Jan 01;12:265-81. (PMID: 17127298)
Mol Cell. 2004 Mar 12;13(5):713-23. (PMID: 15023341)
Cancer Cell. 2017 Jan 9;31(1):127-141. (PMID: 28017614)
J Virol. 2017 Jul 27;91(16):. (PMID: 28592530)
Cancer Treat Res. 2019;177:63-80. (PMID: 30523621)
Nature. 2015 Feb 26;518(7540):560-4. (PMID: 25719671)
Nature. 2014 Jan 2;505(7481):117-20. (PMID: 24284625)
Mol Cancer. 2014 Oct 14;13:233. (PMID: 25311788)
Cancer Treat Res. 2019;177:23-62. (PMID: 30523620)
Annu Rev Cell Dev Biol. 2017 Oct 6;33:319-342. (PMID: 28759256)
Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):370-381. (PMID: 30412798)
J Gen Virol. 2004 Jan;85(Pt 1):147-153. (PMID: 14718629)
معلومات مُعتمدة: BB/M006557/1 United Kingdom BB_ Biotechnology and Biological Sciences Research Council; MR/X000060/1 United Kingdom MRC_ Medical Research Council; MR/R010145/1 United Kingdom MRC_ Medical Research Council; 95505168 United Kingdom MRC_ Medical Research Council
فهرسة مساهمة: Keywords: GPCR5A; KSHV; RNA modification; cell signalling; lytic replication; m6A methylation
المشرفين على المادة: 0 (RNA, Messenger)
تواريخ الأحداث: Date Created: 20230628 Date Completed: 20230629 Latest Revision: 20230701
رمز التحديث: 20230701
مُعرف محوري في PubMed: PMC10303434
DOI: 10.3390/v15061381
PMID: 37376680
قاعدة البيانات: MEDLINE
الوصف
تدمد:1999-4915
DOI:10.3390/v15061381